Osteoarthritis, Hip Clinical Trial
Verified date | July 2017 |
Source | Sanofi |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a clinical study to investigate the safety and efficacy of Synvisc and Depo-Medrol in treating patients with osteoarthritis (OA) of the hip.
Status | Completed |
Enrollment | 0 |
Est. completion date | April 2006 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | All |
Age group | 35 Years and older |
Eligibility |
Inclusion Criteria: - Patients with symptomatic osteoarthritis pain of hip Exclusion Criteria: - Patients with current or prior conditions or treatment that would impede measurement of efficacy and safety |
Country | Name | City | State |
---|---|---|---|
United States | Maryland General Hospital | Baltimore | Maryland |
United States | Alabama Clinical Therapeutics | Birmingham | Alabama |
United States | David S. Tearse, MD (Private Practice) | Cedar Rapids | Iowa |
United States | Chattanooga Center for Sports | Chattanooga | Tennessee |
United States | Northwestern Orthopaedic Institute | Chicago | Illinois |
United States | Orthopedic Specialists of Tamp Bay, P.A. | Clearwater | Florida |
United States | Hughston Sports Medicine Foundation | Columbus | Georgia |
United States | Conway Medical Center | Conway | South Carolina |
United States | Altoona Center for Clinical Research | Duncansville | Pennsylvania |
United States | Family Orthopedic Associates | Flint | Michigan |
United States | Orthopedic Center for Joint Replacement & Sports Medicine | Grants Pass | Oregon |
United States | John Higginbotham, MD Sports Medicine | Huntsville | Alabama |
United States | Lancaster Orthopedic Group | Lancaster | Pennsylvania |
United States | Kansas City Orthopedic Institute | Leawood | Kansas |
United States | Bluegrass Orthopaedics | Lexington | Kentucky |
United States | Arkansas Orthopaedic Specialists | Little Rock | Arkansas |
United States | Cedars-Sinai Orthopedic Center | Los Angeles | California |
United States | Gurdev Gill, MD (Private Practice) | Lubbock | Texas |
United States | Idaho Arthritis & Osteoporosis Center | Meridian | Idaho |
United States | Orthopedic Institute at Mercy Hospital | Miami | Florida |
United States | Illinois Bone and Joint Institute, Ltd. | Morton Grove | Illinois |
United States | UMDNJ-RWJ University Orthopedic Group | New Brunswick | New Jersey |
United States | Hospital for Special Surgery | New York | New York |
United States | Jackson Arthritis Center | Oakland | California |
United States | Health Research Institute | Oklahoma City | Oklahoma |
United States | Allegheny Orthopedic Associates | Pittsburgh | Pennsylvania |
United States | Washington University School of Medicine | Saint Louis | Missouri |
United States | Orthopedic Medical Group | San Diego | California |
United States | Affiliated Orthopedic Specialists | Scottsdale | Arizona |
United States | Arthritis Northwest | Seattle | Washington |
United States | Orthopedic Specialists of Louisiana | Shreveport | Louisiana |
United States | Carilion Bone and Joint Center, Vinton Orthopedic Surgery | Vinton | Virginia |
Lead Sponsor | Collaborator |
---|---|
Genzyme, a Sanofi Company |
United States,
Spitzer AI, Bockow BI, Brander VA, Yates JW, MacCarter DK, Gudger GK, Haller S, Lake SL, Magilavy DB. Hylan G-F 20 improves hip osteoarthritis: a prospective, randomized study. Phys Sportsmed. 2010 Jun;38(2):35-47. doi: 10.3810/psm.2010.06.1781. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pain relief |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05773261 -
Clinical Investigation Comparing Two Different Ultra-porous Coated Surfaces of Uncemented Cups
|
N/A | |
Recruiting |
NCT05223777 -
KINCISEā¢ Surgical Automated System in Total Hip Arthroplasty (THA)
|
N/A | |
Recruiting |
NCT04731077 -
Avenir Complete Post-Market Clinical Follow-Up Study
|
N/A | |
Not yet recruiting |
NCT04448106 -
Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis
|
Phase 2 | |
Completed |
NCT05070871 -
A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women
|
N/A | |
Not yet recruiting |
NCT06162195 -
The ACTIVE Trial: A Prospective Randomised Control Trial Of The H1 Implant Versus Total Hip Replacement
|
N/A | |
Withdrawn |
NCT02743208 -
Evaluation of a Short Femoral Stem in Total Hip Arthroplasty
|
N/A | |
Completed |
NCT02944448 -
A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
|
Phase 2 | |
Active, not recruiting |
NCT02229279 -
Evaluation of Teleconsulting on Rehabilitation After Hip and Knee Surgical Procedures
|
N/A | |
Active, not recruiting |
NCT02851992 -
A Prospective Study to Evaluate Long-term Clinical Outcomes of the GTS Cementless Femoral Stem
|
N/A | |
Completed |
NCT01618708 -
A Study of the Safety and Effectiveness of Synvisc-One® (Hylan G-F 20) in Patients With Primary Osteoarthritis of the Hip
|
N/A | |
Completed |
NCT01700933 -
Dose-response: Exercise Therapy on Hip Osteoarthritis
|
N/A | |
Completed |
NCT01214954 -
Early Rehabilitation After Total Hip Replacement
|
N/A | |
Active, not recruiting |
NCT00294424 -
Study on Costs and Effects of Waiting Time in Total Hip and Knee Replacements
|
N/A | |
Terminated |
NCT00588861 -
Total Hip Replacement With the Answer® Hip Stem and Ranawat/Burnstein® Shell Using Simplex® or Palacos® Bone Cement
|
N/A | |
Withdrawn |
NCT05054595 -
Audio-Recorded vs. Nurse-Led Brief Mindfulness-Based Intervention
|
N/A | |
Terminated |
NCT00973141 -
A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain
|
Phase 2 | |
Recruiting |
NCT05014113 -
H-28 DELTA ST-C and Minima Retrospective Study.
|
||
Completed |
NCT01066936 -
Mini Stem DEXA (Dual Energy X-ray Absorptiometry)
|
||
Recruiting |
NCT05530551 -
Effect of Single vs Multiple Prophylactic Antibiotic Doses on PJI Following Primary THA in Patients With OA
|
N/A |